Alex Hern is an entrepreneur whose career spans over 25 years. His fascination with technology runs deep, especially with the rapidly expanding capabilities of AR. His vision for the future has brought many innovative and interactive applications to the forefront of businesses across the globe.
Alex has co-founded such companies as Inktomi, Yesmail, CloudShield ,NewHomes.com, Triton Network Systems and Zero Knowledge Systems among others. In addition to co-founding, he has stayed on in either a leadership role or as a board member.
TsunamiXR is the latest venture which Alex Hern formed in 2011. Based in Del Mar CA, TsunamiXR is an innovative software platform that offers 3D, virtual reality and augmented reality technologies that have proven to be highly successful for a multitude of industries like aerospace, Industrial, healthcare, energy, automotive and manufacturing. Driving innovation and boosting productivity.
Augmented reality and Virtual Reality basically fall into the same category of technology but AR has become more integrated into business platforms while VR has become more mainstream in entertainment technologies. AR technology allows for a user to interact with the real-world environment, more so than virtual reality and that is the part of this technology that has appealed greatly to software innovators like Alex Hern and TsumamiXR. That being said, VR is extremely useful in some of Tsunami’s applications that are developed for certain industries like engineering and healthcare. That is why Alex still finds VR highly useful in creating software solutions.
As busy as his days are, he is not a fan of multitasking. He believes that the more someone takes on, the less productive they become. He likes to start his day by taking time to focus on an idea or solution that may benefit businesses. He also likes to stay up late when it is quieter and he can again, focus on ideas for developing or improving products or services.
Alex Hern is a true innovator, a thinker and a go-getter and his career speaks volume to the drive and passion he possesses that is the core driver, in changing how we will do business in the future.
Dr. Eric Forsthoefel has been a practicing physician in emergency care for the past six years. He is licensed to practice medicine in Louisiana and Florida. Furthermore, he is certified in emergency medicine by the American Board of Emergency Medicine.
Prior to going to medical school Dr. Eric Forsthoefel received his Bachelor’s degree in religious studies from Florida State University. Following his undergraduate studies Dr. Forsthoefel was admitted to the University of Louisville School of Medicine in 2005 and he graduated in 2009.
Following his successful completion of medical school Dr. Forsthoefel began his residency at the emergency department of Louisiana State University. Dr. Forsthoefel spent two years in his residency at Louisiana State University. It was during these two years of hard work that Dr. Forsthoefel realized that he had a passion for emergency medicine. Emergency medicine doctors are on the frontline of difficult medical cases that occur at all hours of the day. No two cases are exactly the same and emergency medical physicians must be ready to deal with unique cases at a moment’s notice. Dr. Forsthoefel was required to deal with a littany of medical emergencies during his residency from simple illnesses to acute injuries. After three years of long hours and difficult work Dr. Forsthoefel completed his residency at Louisiana State University and returned to Florida to continue working in emergency medicine.
Currently, Dr. Forsthoefel is an emergency medicine physician at Tallahassee Memorial HealthCare. Dr. Forsthoefel has been practicing for the past six years at Tallahassee Memorial HealthCare since the completion of his residency. He is one of twenty-six doctors that specialize in emergency medical care at Tallahassee Memorial. Dr. Forsthoefel is dedicated to ensuring that each patient he encounters receives the best medical care possible in the often hectic and difficult environment of emergency medical care.
Dr. Richard Shinto was appointed to the role of President and CEO for InnovaCare Health after being hired in 2012. InnovaCare Health is the leading and foremost provider of Medicaid and Medicare government health plans. The healthcare company also has an enormous network of physician services.
With a medical degree from the University of New York, Dr. Shinto has a wide range of medical experience and a resume that is impressive. His specialty in the medical profession was a pulmonologist. He received a Master’s Degree from the University of Redlands. Dr. Shinto has also written a variety of articles in the area of medicine and health-related topics. His leadership role in InnovaCare has been credited with the many changes that have positioned the company to expand and bring changes to patient care that has not only been quality-based but also cost-efficient.
Prior to accepting the lead position for Innovacare Health, Dr. Shinto held the position of President and CEO for Aveta Inc., and he was also the Chief Medical Officer of NAMM in California. In 2012, Dr. Shinto was chosen for the Ernst and Young Entrepreneur of the Year Award, which recognized him for having success through innovative ideas and a commitment to business success.
Dr. Shinto’s leadership team includes Penelope Kokkinides, Chief Administrative Officer, who has over 20 years of experience in government programs. Kokkinides joined InnovaCare Health after departing from AmeriChoice, where she was the Executive Vice President in charge of the managed care division. Prior to that tenure, she held an executive position with Touchtone Health Company. Her Master’s Degree was received from Columbia University. Since joining InnovaCare Health, Kokkinides was selected as a panelist to discuss government health plans with the Trump Administration.
The leadership style of Dr. Shinto inspires his team to reach higher and to take risks that are geared towards making the patients success – the company’s success. For instance, when a patient makes an appointment for a Doctor’s visit, InnovaCare Health has made the visit more affordable. The result has been an increase in member enrollment and a lot of positive interaction between the company and the patients. In Puerto Rico, patients have improved access to treatment because of the advanced technology that InnovaCare Health has invested for their medical care. In fact, there are 70 percent more Peurto Rican patients that have chosen health care coverage plans from Innovacare Health than any other plan. The business model that the company has implemented uses a “patient first” approach, which has garnered a lot of trust among those in the community.
The world of science is filled with discoveries that have yet to be tapped. A majority of companies that deal with scientific research have been making enormous strides to make new discoveries in their area of expertise. One such company is Seattle Genetics. The heart of Seattle Genetics research is human antibodies. Seattle Genetics studies, manipulates, and ultimately comes up with drug that can assist the human antibodies perform their functions better. Clay Siegall founded the research company in the year 1988. The antibodies that Seattle Genetics produces, have the ability that ordinary antibodies do not. The antibodies they manufacture have the ability to deliver a toxic payload to the cancer cells in the body causing them to destroy it from the inside out.
The development of such antibodies could catapult Seattle Genetics to greater heights. With steady growth over the years, the recent research findings could catapult the company to big league category. With a market value of over $10 billion and 900 employees, the company has risen to become one of the largest biotech companies in Washington. It has further grand ambitions of being among the few companies that graduate from a biotech company to a big pharmaceutical company. However, to achieve this dream, they have invested heavily in research and marketing. The additional workforce of 200 employees will help ease the burden of the great tasks they have to accomplish their goal.
One of the achievements of Seattle Genetics is its flagship drug known as Adcetris. The medicine treats Hodgkin lymphoma. Hodgkin lymphoma is a type of cancer that affects the lymph system and can spread if not detected earlier. If the tests that are underway on the drug prove responsive, selling the drug could be a possibility. Clay Siegall, the founder, chairman, and CEO of Seattle Genetics sees a bright future for the company. His ambitions for Seattle Genetics are clear as his desire for the company to move from being a biotech company and focus more on the development of drugs. Clay Siegall has over 20 years’ experience in the study and research of cancer and therapeutic drug development. His in-depth knowledge has helped Seattle Genetics rise to its current position. Apart from being the founder, CEO, and Chairman of Seattle Genetics, he is an author of 67 scientific papers and a holder of 9 patents. He also serves on the three scientific journal editorial boards.